Related Experiment Video

Updated: Jun 30, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

[Subcellular re-distribution of F-actin in MCF7 cells upon inducible expression of CDKN2A/p16INK4a]

Jianqing Liang1, Manna Wang2, Zhengrong Zhang2

  • 1School of Biological Science and Engineering, South China University of Technology, Guangzhou 510000; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|April 12, 2017
PubMed

Insights

The cyclin-dependent kinase inhibitor CDKN2A/p16INK4a increases breast cancer cell size and alters actin cytoskeleton organization. This study demonstrates p16INK4a

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • CDKN2A/p16INK4a is a cyclin-dependent kinase inhibitor involved in cell cycle regulation.
  • Understanding p16INK4a's role in breast cancer cell morphology and cytoskeleton is crucial for targeted therapies.
  • MCF7 breast cancer cells were used as a model system, lacking endogenous p16INK4a expression.

Purpose of the Study:

  • To investigate the impact of inducible CDKN2A/p16INK4a expression on MCF7 breast cancer cell morphology.
  • To analyze the effects of p16INK4a on the cell cytoskeleton and intercellular adhesion.
  • To establish a Tet-on inducible system for controlled p16INK4a expression in MCF7 cells.

Main Methods:

  • A Tet-on inducible gene expression system was employed to control p16INK4a expression in MCF7 cells.
  • Doxycycline (Dox) treatment induced p16INK4a expression.
  • Cell proliferation, cell size, intercellular adhesion (E-cadherin), and F-actin cytoskeleton were analyzed using cell counting, microscopy, and fluorescent staining.

Main Results:

  • A stable MCF7 cell line with Dox-inducible p16INK4a expression was successfully generated.
  • p16INK4a expression inhibited cell proliferation and significantly increased cell size.
  • Intracellular F-actin redistributed to the cell periphery, and intercellular adhesion was weakened.

Conclusions:

  • Inducible p16INK4a expression in MCF7 cells alters cell morphology, leading to increased cell size.
  • p16INK4a negatively impacts intercellular adhesion in these breast cancer cells.
  • Cortical re-distribution of cytoskeletal F-actin is a key effect of p16INK4a in MCF7 cells.

More Related Videos

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes09:41

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes

Published on: February 24, 2017

Quantification of Cell-Substrate Adhesion Area and Cell Shape Distributions in MCF7 Cell Monolayers06:46

Quantification of Cell-Substrate Adhesion Area and Cell Shape Distributions in MCF7 Cell Monolayers

Published on: June 24, 2020

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...